Cutting Proportion of RNs on Care Teams Tied to Worse Outcomes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 29, 2024 -- Reducing the proportion of registered nurses (RNs) in hospitals, even when total nursing personnel hours are kept the same, is likely to result in significantly worse outcomes, according to a study published in the July issue of Medical Care.
Karen B. Lasater, Ph.D., R.N., from the School of Nursing at the University of Pennsylvania in Philadelphia, and colleagues evaluated whether reducing the proportion of RNs to total nursing staff in hospitals is in the best interest of patients, hospitals, and payers. The analysis included data from 6.6 million Medicare patients seen in 2,676 general acute care U.S. hospitals in 2019.
The researchers found that a 10 percentage-point reduction in RNs was associated with 7 percent higher odds of in-hospital death, 1 percent higher odds of readmission, a 2 percent increase in expected days, and lower patient satisfaction. An estimated 10,947 avoidable deaths annually and 5,207 avoidable readmissions would result from a 10 percentage-point reduction in RNs, translating to roughly $68.5 million in additional Medicare costs. Furthermore, because of patients requiring longer stays, hospitals would forgo nearly $3 billion in cost savings annually.
"Estimates represent only a 10 percentage-point dilution in skill mix; however, the team nursing model includes much larger reductions of 40 to 50 percentage-points -- the human and economic consequences of which could be substantial," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-30 09:03
Read more
- Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
- Use of Fan, Skin Wetting Reduces Cardiac Strain in Hot, Humid Conditions
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Infectious Diseases Society of America, Oct. 16-19
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- Rising Temperatures Increase Risk for Poor Maternal, Neonatal Outcomes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions